Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.925
-0.005 (-0.26%)
Jul 15, 2026, 12:31 PM EDT - Market open
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $116.12 million as of July 15, 2026. Its market cap has decreased by -49.38% in one year.
Market Cap
116.12M
Enterprise Value
66.93M
1-Year Change
-49.38%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $116.12M, an increase of 212.15%. That is a compound annual growth rate of 9.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 116.12M | -62.73% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 139.11M |
| Spruce Biosciences | 137.81M |
| Genelux | 134.56M |
| ProMIS Neurosciences | 127.79M |
| enGene Therapeutics | 127.28M |
| Fractyl Health | 125.76M |
| Coya Therapeutics | 123.38M |
| Spero Therapeutics | 121.59M |